| Screening of SDS-degrading bacteria from car wash wastewater and study of the alkylsulfatase enzyme activity R Shahbazi, R Kasra-Kermanshahi, S Gharavi, Z Moosavi-Nejad, ... Iranian journal of microbiology 5 (2), 153, 2013 | 53 | 2013 |
| Radio-resistance in psychrotrophic Kocuria sp. ASB 107 isolated from Ab-e-Siah radioactive spring E Asgarani, MR Soudi, F Borzooee, R Dabbagh Journal of environmental radioactivity 113, 171-176, 2012 | 37 | 2012 |
| Structure-based design of first-generation small molecule inhibitors targeting the catalytic pockets of AID, APOBEC3A, and APOBEC3B JJ King, F Borzooee, J Im, M Asgharpour, A Ghorbani, CP Diamond, ... ACS Pharmacology & Translational Science 4 (4), 1390-1407, 2021 | 12 | 2021 |
| APOBEC3G regulation of the evolutionary race between adaptive immunity and viral immune escape is deeply imprinted in the HIV genome F Borzooee, KD Joris, MD Grant, M Larijani Frontiers in immunology 9, 414089, 2019 | 12 | 2019 |
| Viral subversion of APOBEC3s: lessons for anti-tumor immunity and tumor immunotherapy F Borzooee, M Asgharpour, E Quinlan, MD Grant, M Larijani International Reviews of Immunology 37 (3), 151-164, 2018 | 11 | 2018 |
| Pichia pastoris as a host for production and isolation of mutagenic AID/APOBEC enzymes involved in cancer and immunity F Borzooee, M Larijani New biotechnology 51, 67-79, 2019 | 9 | 2019 |
| Optimal conditions for enhancing sodium dodecyl sulfate biodegradation by Pseudomonas aeruginosa KGS R Shahbazi, R Kasra-Kermanshahi, S Gharavi, Z Moosavi-Nejad, ... Progress in Biological Sciences 3 (2), 107-115, 2013 | 2 | 2013 |
| Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier S Grasedieck, A Panahi, MC Jarvis, F Borzooee, RS Harris, M Larijani, ... Leukemia, 1-6, 2024 | | 2024 |
| OA-21 Dysregulated APOBEC3B promotes cell proliferation and DNA damage in multiple myeloma A Panahi, S Grasedieck, F Borzooee, M Jarvis, R Harris, M Larijani, ... Clinical Lymphoma Myeloma and Leukemia 23, S13, 2023 | | 2023 |
| An APOBEC/Inflammation-based classifier improves the stratification of multiple myeloma patients and identifies novel risk subgroups S Grasedieck, A Panahi, MC Jarvis, F Borzooee, RS Harris, M Larijani, ... | | 2022 |
| P-150: Identification of misclassified multiple myeloma patient risk subgroups with a novel biological disease stratifier A Panahi, S Grasedieck, M Jarvis, F Borzooee, R Harris, M Larijani, ... Clinical Lymphoma Myeloma and Leukemia 22, S117-S118, 2022 | | 2022 |
| Identification of Previously Unrecognized Multiple Myeloma Risk Subgroups with a Novel Biological Disease Stratifier AM Shariatpanahi, S Grasedieck, MC Jarvis, F Borzooee, RS Harris, ... Blood 138, 4718, 2021 | | 2021 |
| P-120: Improving the risk stratification of multiple myeloma with a nucleotide editor/inflammation-based scoring system AM Shariatpanahi, S Grasedieck, MC Jarvis, F Borzooee, R Harris, ... Clinical Lymphoma Myeloma and Leukemia 21, S100, 2021 | | 2021 |
| Examining the role of genome editing enzymes in anti tumor immunity F Borzooee Cancer Research 81 (13_Supplement), 1483-1483, 2021 | | 2021 |
